secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2026-07-15T20:15:43+00:00
Accession:  0001493152-26-033360
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026
-----------------------------------------------------------------------

- Jeffrey Millard resigned as Chief Operating Officer on July 10, 2026.
- Resignation notice received and effective on the same date.
- No replacement or interim COO has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/0001493152-26-033360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer